Product Categories
| Country: | China |
|---|---|
| Tel: | 13720134139 086-15871494362 |
| Mobile: | +8613720134139 |
| E-mail: | orders@jknbiochem.com |
| QQ: | 3655618288 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 58468-07-4 | Details |
| Hydrocortisone Sodium Succinate | C25H33O8.Na | 125-04-2 | Details |
| Navivumab | 1443004-16-7 | Details |
| Trevogrumab | 1429201-24-0 | Details |
| Afasevikumab | 1589503-30-9 | Details |
| Lanadelumab | 1426055-14-2 | Details |
| Dezamizumab | 1662664-56-3 | Details |
| Meplazumab | 2413715-21-4 | Details |
| Prednisolone Valeroacetate | C28H38O7 | 72064-79-0 | Details |
| Prednisolone Hemisuccinate | C25H32O8 | 2920-86-7 | Details |
| Hydrocortisone-17-butyrate | C25H36O6 | 13609-67-1 | Details |
| Gepotidacin | C24H28N6O3 | 1075236-89-3 | Details |
| Enoblituzumab | 1353485-38-7 | Details |
| Bermekimab | 1401965-15-8 | Details |
| Inebilizumab | 1299440-37-1 | Details |
| Tezepelumab | 1572943-04-4 | Details |
| Landogrozumab | 1391726-30-9 | Details |
| Prezalumab | 1523164-68-2 | Details |
| Vadastuximab | 1436390-63-4 | Details |
| C22 H20 Cl N5 O3 S | 1887069-10-4 | Details |
| Sevirumab | 138660-96-5 | Details |
| C27H26ClF2N3O4 | 2714434-21-4 | Details |
| cortisol sodium phosphate | C21H29O8P.2Na | 6000-74-4 | Details |
| Hydrocortisone 17-valerate | C26H38O6 | 57524-89-7 | Details |
| Tesidolumab | 1531594-08-7 | Details |
| Lilotomab | 1453362-55-4 | Details |
| Ascrinvacumab | 1463459-96-2 | Details |
| Rovalpituzumab | 1613313-01-1 | Details |
| Xentuzumab | 1417158-65-6 | Details |
| Crotedumab | 1452387-69-7 | Details |
| Birtamimab | 1608108-91-3 | Details |
| Rozanolixizumab | 1584645-37-3 | Details |
| 4-[4-(4-amino-1,2,5-oxadiazol-3-yl)-2-oxido-1,2,5-oxadiazol-3-yl]-1,2,5-oxadiazol-3-amine | C6H4N8O4 | 296244-55-8 | Details |
| Fmoc-N'-methyltrityl-L-lysine | C41H40N2O4 | 167393-62-6 | Details |
| Clascoterone | C24H34O5 | 19608-29-8 | Details |
| Indusatumab Vedotin | 1514889-12-3 | Details |
| Opicinumab | 1422268-07-2 | Details |
| Tisotumab | 1418628-81-5 | Details |
| Olendalizumab | 1337966-73-0 | Details |
| Naratuximab | 1622327-39-2 | Details |
| Vonlerolizumab | 1638935-72-4 | Details |
| Prednisone Phosphate Disodium Salt/17-Hydroxy-21-(phosphonooxy)pregna-1,4-diene-3,11,20-trione disodium salt | C21H25Na2O8P | 33903-70-7 | Details |
| C16H16ClN3 | 138729-68-7 | Details |
| prednisolon | C21H28O5 | 50-24-8 | Details |
| Galcanezumab | 1578199-75-3 | Details |
| Istiratumab | 1509928-04-4 | Details |
| Rinucumab | 1569263-06-4 | Details |
| Tilavonemab | 2096513-89-0 | Details |
| Carotuximab | 1268714-50-6 | Details |
| Elezanumab | 1791416-49-3 | Details |
| Fludrocortisone acetate | C23H31FO6 | 514-36-3 | Details |
| Anecortave Acetate | C23H30O5 | 7753-60-8 | Details |
| Brolucizumab | 1531589-13-5 | Details |
| Monalizumab | 1228763-95-8 | Details |
| Refanezumab | 1233953-61-1 | Details |
| Rivabazumab | 1627519-84-9 | Details |
| Suptavumab | 1629615-23-1 | Details |
| Lupartumab | 1640971-88-5 | Details |
| Budesonide | C25H34O6 | 51372-29-3 | Details |
| Cortisone | C21H28O5 | 53-06-5 | Details |
| Prednisolone phosphate sodium | C21H27Na2O8P | 125-02-0 | Details |
| Andecaliximab | 1518996-49-0 | Details |
| Research Grade Nemolizumab | 1476039-58-3 | Details |
| Plozalizumab | 1610761-46-0 | Details |
| Satralizumab | 1535963-91-7 | Details |
| Blontuvetmab | 1608112-78-2 | Details |
| Domagrozumab | 1629605-31-7 | Details |
| Research Grade Apamistamab | 2097132-02-8 | Details |
| BEMPEDOIC ACID | C19H36O5 | 738606-46-7 | Details |
| Difluprednate | C27H34F2O7 | 23674-86-4 | Details |
| Pepinemab | 2097151-87-4 | Details |
| Research Grade Cergutuzumab | 1509916-03-3 | Details |
| Research Grade Gontivimab | 1257358-38-5 | Details |
| Laprituximab | 1622327-38-1 | Details |
| Timolumab | 1073538-99-4 | Details |
| Lutikizumab | 1791411-57-8 | Details |
| ZN-c3 | C29H34N8O2 | 2376146-48-2 | Details |
| MK-1775 | C27H32N8O2 | 955365-80-7 | Details |
| Eptinezumab | 1644539-04-7 | Details |
| Fremanezumab | 1655501-53-3 | Details |
| Obiltoxaximab | 1351337-07-9 | Details |
| Deflazacort | C25H31NO6 | 14484-47-0 | Details |
| Indusatumab | 1497400-26-6 | Details |
| Bleselumab | 1453067-91-8 | Details |
| Research Grade Ifabotuzumab | 1234137-51-9 | Details |
| Mirvetuximab | 1453084-36-0 | Details |
| Navicixizumab | 1638338-43-8 | Details |
| Research Grade Setrusumab | 1847394-95-9 | Details |
| Depatuxizumab | 1471999-69-5 | Details |
| loteprednol etabonate | C24H31ClO7 | 82034-46-6 | Details |
| 11α-Hydroxyprogesterone | C21H30O3 | 80-75-1 | Details |
| Burosumab | 1610833-03-8 | Details |
| Elgemtumab | 1512559-37-3 | Details |
| Isatuximab | 1461640-62-9 | Details |
| Clivatuzumab Tetraxetan | 1462876-11-4 | Details |
| Cabiralizumab | 1613144-80-1 | Details |
| Tamtuvetmab | 1608122-71-9 | Details |
| Erenumab | 1582205-90-0 | Details |
| Duvortuxizumab | 1831098-91-9 | Details |
| Triamcinolone Acetonide EP Impurity E | C24H33FO6 | 1524-86-3 | Details |
| Product Total： Product Page： | ||||
| 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 | ||||